Medical Marijuana, Inc.
MJNA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.04 | -0.01 | 0.16 |
| FCF Yield | 48.09% | -43.89% | -78.98% | -6.17% |
| EV / EBITDA | -51.98 | -3.97 | -1.96 | -17.90 |
| Quality | ||||
| ROIC | -0.00% | -7.15% | -7.55% | -2.40% |
| Gross Margin | 78.22% | 66.89% | 73.54% | 78.72% |
| Cash Conversion Ratio | -1.52 | 0.50 | 0.96 | 0.94 |
| Growth | ||||
| Revenue 3-Year CAGR | -15.94% | -21.02% | -18.83% | -23.28% |
| Free Cash Flow Growth | 114.16% | 60.81% | -291.46% | 95.31% |
| Safety | ||||
| Net Debt / EBITDA | -24.51 | -0.64 | -0.46 | 0.15 |
| Interest Coverage | -0.00 | -38.76 | -89.69 | -6.98 |
| Efficiency | ||||
| Inventory Turnover | 2.55 | 3.11 | 2.71 | 2.71 |
| Cash Conversion Cycle | -104.58 | -21.00 | 38.10 | 102.08 |